Listen Now: 
October 31, 2024
Report exposes gaps in blood cancer medications
Atereano Mateariki
Posted On October 31, 2024
Download AudioA new report by Te Aho o Te Kahu (New Zealand Cancer Control Agency) reveals significant gaps in access to funded blood cancer medications in New Zealand compared to Australia.
Last week, the report Te Rere o te Toto found that while 58 cancer medications are available in both New Zealand and Australia, New Zealand offers 13 unique medicines.
However, Australia has 24 medications that are not available in New Zealand, including 12 with notable clinical benefits.
Myra Ruka, co-lead of the Cancer National Clinical Network, says this report is the first of its kind and will support PHARMAC’s efforts to increase publicly funded medication options.
It’s heartbreaking to see whānau face cancer journeys where access to treatment could mean years of quality life instead of just weeks or months
“It’s those experiences that keep a lot of us who are involved in this space really motivated and passionate to keep pushing for what we know is within our grasp. You know, these, these medications, are within our grasp. So it’s about keeping our voices really strong, unified and clear,” says Ruka.
RELATED NEWS
